Abbott Facing FDA Consent Decree Over Alleged QSR Violations
This article was originally published in The Gray Sheet
Executive Summary
Discussions between Abbott Labs and FDA over a proposed consent decree that could halt production of certain diagnostic products likely relate to quality system regulations (QSR) violations detected over a year ago at the firm's Abbott Park, Illinois facility.